S. Settatree

969 total citations · 1 hit paper
10 papers, 702 citations indexed

About

S. Settatree is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, S. Settatree has authored 10 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in S. Settatree's work include Prostate Cancer Treatment and Research (3 papers), Hormonal and reproductive studies (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). S. Settatree is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Hormonal and reproductive studies (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). S. Settatree collaborates with scholars based in United Kingdom and Australia. S. Settatree's co-authors include Johann S. de Bono, David P. Dearnaley, Elizabeth Folkerd, J. W. Clark, Mitch Dowsett, Timothy A. Yap, Mary Barrett, Gerhardt Attard, Florence I. Raynaud and Alison Reid and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Molecular Cancer Therapeutics.

In The Last Decade

S. Settatree

10 papers receiving 689 citations

Hit Papers

Phase I Clinical Trial of a Selective Inhibitor of CYP17,... 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
    2008 666 citations Gerhardt Attard, Alison Reid et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Settatree United Kingdom 5 572 271 194 170 149 10 702
Emilda Thompson United Kingdom 4 658 1.2× 292 1.1× 223 1.1× 178 1.0× 164 1.1× 7 766
Mary Barrett United Kingdom 4 589 1.0× 275 1.0× 226 1.2× 327 1.9× 160 1.1× 7 923
Nikhil Babu Oommen United Kingdom 6 904 1.6× 383 1.4× 366 1.9× 255 1.5× 212 1.4× 7 1.1k
Gal Maier United Kingdom 3 659 1.2× 204 0.8× 235 1.2× 142 0.8× 229 1.5× 5 713
Nicholas I. Simon United States 11 521 0.9× 178 0.7× 253 1.3× 240 1.4× 75 0.5× 31 720
Riikka Oksala Finland 9 365 0.6× 169 0.6× 127 0.7× 136 0.8× 88 0.6× 20 492
Julia Shelkey United States 6 821 1.4× 194 0.7× 303 1.6× 239 1.4× 246 1.7× 9 956
Mohammad Alyamani United States 13 522 0.9× 317 1.2× 142 0.7× 219 1.3× 84 0.6× 19 709
Stephen Balk United States 6 720 1.3× 295 1.1× 436 2.2× 458 2.7× 96 0.6× 8 1.0k
Vanessa Martins United Kingdom 10 929 1.6× 403 1.5× 331 1.7× 416 2.4× 236 1.6× 14 1.3k

Countries citing papers authored by S. Settatree

Since Specialization
Citations

This map shows the geographic impact of S. Settatree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Settatree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Settatree more than expected).

Fields of papers citing papers by S. Settatree

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Settatree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Settatree. The network helps show where S. Settatree may publish in the future.

Co-authorship network of co-authors of S. Settatree

This figure shows the co-authorship network connecting the top 25 collaborators of S. Settatree. A scholar is included among the top collaborators of S. Settatree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Settatree. S. Settatree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kirby, Anna M., Imogen Locke, S. Settatree, et al.. (2025). Oncotype DX Breast DCIS Score® Test: Impact on Radiotherapy Recommendations and Patient Decisional Anxiety. Clinical Oncology. 42. 103839–103839. 1 indexed citations
2.
Settatree, S., Alex Dunlop, Douglas Brand, et al.. (2021). What Can Proton Beam Therapy Achieve for Patients with Pectus Excavatum Requiring Left Breast, Axilla and Internal Mammary Nodal Radiotherapy?. Clinical Oncology. 33(12). e570–e577. 5 indexed citations
3.
Hunt, A., S. Settatree, Dualta Mcquaid, et al.. (2021). Interobserver variability in target volume delineation for CT/MRI simulation and MRI-guided adaptive radiotherapy in rectal cancer. British Journal of Radiology. 94(1128). 20210350–20210350. 10 indexed citations
4.
Attard, Gerhardt, Alison Reid, Timothy A. Yap, et al.. (2008). Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven. Journal of Clinical Oncology. 26(28). 4563–4571. 666 indexed citations breakdown →
5.
Attard, Gerhardt, Alison Reid, Rajesh Kumar Sinha, et al.. (2007). Selective inhibition of CYP17 with abiraterone acetate is well tolerated and results in a high response rate in castration-resistant prostate cancer (CRPC). Molecular Cancer Therapeutics. 6. 1 indexed citations
6.
Reid, Alison, James Spicer, Elisa Gallerani, et al.. (2007). An exploration of the ability of DCE-CT scans to evaluate blood flow in an open, pharmacokinetic (PK) and mass balance study of 14[C]-cediranib. 6. 3 indexed citations
7.
8.
9.
Reid, Alison, James Spicer, Elisa Gallerani, et al.. (2007). An open, pharmacokinetic (PK) and mass balance study of 14C-AZD2171, incorporating DCE-CT evaluations. Journal of Clinical Oncology. 25(18_suppl). 14140–14140. 3 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilda Thompson Breakdown of academic impact, for papers by Mary Barrett Breakdown of academic impact, for papers by Nikhil Babu Oommen Breakdown of academic impact, for papers by Gal Maier Breakdown of academic impact, for papers by Nicholas I. Simon Breakdown of academic impact, for papers by Riikka Oksala Breakdown of academic impact, for papers by Julia Shelkey Breakdown of academic impact, for papers by Mohammad Alyamani Breakdown of academic impact, for papers by Stephen Balk Breakdown of academic impact, for papers by Vanessa Martins
Rankless by CCL
2026